相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
2018300-62-2
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1110.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥477.0 |
| 规格: | 5 mg | 产品价格: | ¥1050.0 |
| 规格: | 10 mg | 产品价格: | ¥1800.0 |
| 规格: | 50 mg | 产品价格: | ¥4800.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
TPOP146
CAS No. : 2018300-62-2
MCE 国际站:TPOP146
产品活性:TPOP146是选择性的CBP/P300苯并西泮溴结构域抑制剂;对CBP和BRD4的Kd值分别为134 nM和5.02 μM。
研究领域:Epigenetics
作用靶点:Epigenetic Reader Domain | Histone Acetyltransferase
In Vitro: Exposure to 1 μM TPOP146 results in a significant decrease of recovery half-life that is comparable to the construct that contained the bromodomain inactivating mutation N1168F, demonstrating that TPOP146 targets the CBP bromodomain in the nucleus and is capable of competing with acetyl-lysine mediated interactions of the CBP bromodomain in cellular environments.
相关产品:Bioactive Compound Library Plus | Epigenetics Compound Library | Histone Modification Research Compound Library | Anti-Cancer Compound Library | Reprogramming Compound Library | Anti-Blood Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Heterocyclic Compound Library | Highly Selective Inhibitors Library | (+)-JQ-1 | Curcumin | Acetaminophen | A-485 | C646 | Revumenib | BRM/BRG1 ATP Inhibitor-1 | BI 2536 | dBET6 | MZ 1 | ARV-825 | Inobrodib | Birabresib | Remodelin hydrobromide | 666-15 | SGC-CBP30 | VTP50469 | ACBI1 | WM-3835 | AU-15330 | PF-9363 | ARV-771 | I-BET151 | dBET1 | dCBP-1 | ABBV-744 | Anacardic Acid | Molibresib | NSC 228155
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















